News & Analysis as of

Physicians › JAMA

Goodwin

JAMA Article: Obstacles to the Adoption of Biosimilars for Chronic Diseases

Goodwin on

Generic drugs currently account for 88% of all U.S. prescriptions, yielding 10-year cost savings in excess of $1.5 trillion. There is some optimism that biosimilars will offer a similar low-cost therapeutic alternative to...more

Arnall Golden Gregory LLP

Pharmaceutical Industry-Sponsored Meals and Prescribing Rates: New Research Shows Link

Arnall Golden Gregory LLP on

A new report published in the Journal of the American Medical Association (JAMA) has noted a link between pharmaceutical industry payments to physicians and prescribing rates for brand-name medication. Specifically, the study...more

Robinson & Cole LLP

JAMA Releases Study Analyzing Scope and Characteristics of Recent Data Breaches

Robinson & Cole LLP on

Reports of security breaches involving health care information have become increasingly prevalent in recent years, and such breaches seem to be continually growing in scope and magnitude. In the April 14, 2015, issue of JAMA,...more

Sheppard Mullin Richter & Hampton LLP

Exploring the Relationship Between Price and Competition Among Physician Practices

Sheppard Mullin Richter & Hampton LLP on

The latest from the Journal of the American Medical Association (JAMA) is a thematic issue organized around a prominent topic in healthcare: price, cost, and competition. Contributing to the debate is an article titled,...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide